Escherichia coli-associated hemolytic uremic syndrome and severe chronic hepatocellular cholestasis: complication or side effect of eculizumab?-Reference-Cited by-同舟云学术

Escherichia coli-associated hemolytic uremic syndrome and severe chronic hepatocellular cholestasis: complication or side effect of eculizumab?

Published:2019-04-08 Issue:7 Volume:34 Page:1289-1293
ISSN:0931-041X
Container-title:Pediatric Nephrology
language:en
Short-container-title:Pediatr Nephrol

Author:

Mauras Mathilde,Bacchetta Justine,Duncan Anita,Lavocat Marie-Pierre,Rohmer Barbara,Javouhey Etienne,Collardeau-Frachon Sophie,Sellier-Leclerc Anne-Laure^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Nephrology,Pediatrics, Perinatology, and Child Health

Link

http://link.springer.com/content/pdf/10.1007/s00467-019-04234-6.pdf

Reference15 articles.

1. Fakhouri F, Zuber J, Frémeaux-Bacchi V, Loirat C (2017) Haemolytic uraemic syndrome. Lancet 390:681–696. https://doi.org/10.1016/S0140-6736(17)30062-4

2. de Buys Roessingh AS, de Lagausie P, Baudoin V, Loirat C, Aigrain Y (2007) Gastrointestinal complications of post-diarrheal hemolytic uremic syndrome. Eur J Pediatr Surg 17:328–334. https://doi.org/10.1055/s-2007-965013

3. Lapeyraque A-L, Malina M, Fremeaux-Bacchi V, Boppel T, Kirschfink M, Oualha M, Proulx F, Clermont MJ, Le Deist F, Niaudet P, Schaefer F (2011) Eculizumab in severe Shiga-toxin-associated HUS. N Engl J Med 364:2561–2563. https://doi.org/10.1056/NEJMc1100859

4. Brady TM, Pruette C, Loeffler LF, Weidemann D, Strouse JJ, Gavriilaki E, Brodsky RA (2016) Typical Hus: evidence of acute phase complement activation from a daycare outbreak. J Clin Exp Nephrol 1:11

5. Urushihara N, Ariki N, Oyama T, Chouda Y, Yagi T, Inoue T, Tomiyama Y, Nishiuchi R, Oda M, Tanaka N (2001) Secondary sclerosing cholangitis and portal hypertension after O157 enterocolitis: extremely rare complications of hemolytic uremic syndrome. J Pediatr Surg 36:1838–1840. https://doi.org/10.1053/jpsu.2001.28858

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world safety profile of eculizumab: an analysis of FDA adverse event reporting system and systematic review of case reports;Expert Opinion on Drug Safety;2024-08-26

2. The role of complement in kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference;Kidney International;2024-06

3. Complement inhibitors in pediatric kidney diseases: new therapeutic opportunities;Pediatric Nephrology;2023-09-21

4. Case Report: Neonatal Unexplained HUS Treated With Complement Inhibitor Eculizumab;Frontiers in Pediatrics;2021-02-18

5. Escherichia coli;Foodborne Infections and Intoxications;2021